Status:
COMPLETED
Effect of Transcranial Static Magnetic Field Stimulation in Fibromyalgia Syndrome
Lead Sponsor:
University of Seville
Conditions:
Fibromyalgia
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
The main objective is to know if the transcranial static magnetic field stimulation (tSMS) reduces the perception of pain in patients with fibromyalgia and its effect on health-related quality of life...
Detailed Description
Background: Various non-invasive brain stimulation techniques have been successfully tested in fibromyalgia syndrome (FMS). Transcranial static magnetic field stimulation (tSMS) is a new, portable an...
Eligibility Criteria
Inclusion
- Formal diagnosis of fibromyalgia syndrome (FMS).
- No change in the last 4 weeks on their standard treatment.
- They must have pain for more than 6 months (at least 4 on the VAS scale).
- Score on the fibromyalgia impact questionnaire (FIQ) greater than 39.
Exclusion
- Presence of concomitant autoimmune or hematologic diseases.
- Neuropsychiatric disorders.
- Pacemakers or neurostimulators implants.
- Substance abuse or other pathologies that can explain chronic pain.
- Pregnant or lactating women.
- Those who are receiving any other type of physiotherapy treatment.
Key Trial Info
Start Date :
April 19 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 30 2021
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT04836325
Start Date
April 19 2021
End Date
November 30 2021
Last Update
June 8 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Grupo de Investigación Área de Fisioterapia CTS 305 - Universidad de Sevilla
Seville, Spain, 41009